PIK3R1 and ovarian carcinoma: A functional study demonstrated that PIK3R1 was highly expressed in CDDP-resistant ovarian cancer cells, and downregulated PIK3R1 resensitized the abovementioned cells to platinum-based treatment, which reveals the promising involvement of p85α in secondary CDDP resistance [24].